The results of research on the antioxidant emoksipin in clinical eye diseases

Egorov, E.A.; Shvedova, A.A.; Obraztsova, I.A.

Vestnik Oftalmologii 105(5): 52-55

1989


ISSN/ISBN: 0042-465X
PMID: 2595902
Document Number: 4751
Emoxipin, a new lipid peroxidation inhibitor, has been used in the treatment of various ophthalmic diseases. The drug is characterized by a retinal-protective and an additional fibrinolytic effects; it has been effectively used to preserve the visual function in glaucoma, to treat intraocular hemorrhages and retinal injuries with physical, chemical, or bacterial factors. A manifest effect has been observed in 87% of 106 patients (118 eyes) with various ocular abnormalities. Emoxipin is recommended for the treatment of a variety of ocular diseases.

Document emailed within 1 workday
Secure & encrypted payments

The results of research on the antioxidant emoksipin in clinical eye diseases